Back to BlackRock, Inc.

PTGX
6 quarters

Position history for BlackRock, Inc.'s holdings in PROTAGONIST THERAPEUTICS INC

BlackRock, Inc. holds 9.8M shares of PTGX (PROTAGONIST THERAPEUTICS INC), worth $1B as of 2026-Q1. The position was increased (+0.7% shares). PTGX represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$1B

Current Shares

9.8M

Total Value Change

+$649.2M

Total Shares Change

-105,248

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
9.8M
+0.7%
$1B0.0%$91.30
32
2025-Q4
Increased
9.7M
+3.3%
$848.6M0.0%$87.26
33
2025-Q3
Decreased
9.4M
-2.4%
$624.7M0.0%$65.14
0
2025-Q2
Decreased
9.6M
-1.1%
$532.3M0.0%$55.69
0
2025-Q1
Decreased
9.7M
-1.5%
$470.9M0.0%$48.88
0
2024-Q4
New
9.9M
-
$381.5M0.0%$38.51
43

Other major holders of PTGX: FARALLON CAPITAL MANAGEMENT, L.L.C., UBS Group AG, RTW INVESTMENTS, LP, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used